Nama Insights

Tenet Healthcare (THC)

Healthcare · Medical Care Facilities · NYSE

Tenet Healthcare (THC) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $22.55B, a trailing price-to-earnings ratio of 12.7 and a free-cash-flow yield of 9.8%. Over the most recent reported fiscal year, revenue grew 3.1% and free cash flow per share grew 144.3%. Nama's AI scorecard rates it Buy, 8.1 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Buy · 8.1/10
Clearly positive, short of the top band. As of Nov 7, 2026.
Momentum
Rising · +27.3% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-6.0%
How far the last close sits under the highest price of the past five years.
Market cap$22.55B
Trailing P/E12.7
Price / book4.1
Price / sales1.0
FCF yield9.8%
Dividend yield—
Gross margin83.3%
Operating margin22.5%
Net margin12.3%
Revenue growth (YoY)+3.1%
Revenue growth (3-yr annual)+3.6%
EPS growth (YoY)+41.0%
FCF/share growth (YoY)+144.3%
Beta1.2
ExchangeNYSE
SectorHealthcare
IndustryMedical Care Facilities

THC earnings

Next report: Feb 10, 2027 (Q4 2026, EPS estimate $5.41). Beat the EPS estimate in 4 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Oct 29, 2026 $6.64 $4.68 +41.9% $6.28B
Q2 2026 Jul 23, 2026 $6.12 $4.26 +43.7% $6.04B
Q1 2026 Apr 30, 2026 $4.82 $4.17 +15.6% $5.78B
Q4 2025 Feb 11, 2026 $4.70 $4.07 +15.5% $5.53B

THC analyst price target

Median target $303.50 from 22 analysts, ranging $265.00 – $342.00.

Medical Care Facilities peers

TickerCompanyMarket capP/E
HCA HCA Healthcare $103.40B 16.5
EHC Encompass Health $13.50B 22.4
FMS Fresenius Medical Care $12.15B 10.2
DVA DaVita $12.04B 13.6
UHS Universal Health Services $11.52B 8.6
ENSG Ensign Group $10.56B 23.8
PACS PACS Group $7.87B 20.1
CHE Chemed $6.84B 21.2
Explore live THC data on Nama Insights →

Recent Congressional trades

Tenet Healthcare trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Jonathan Jackson House Sell $15,001 - $50,000 May 27, 2026
Jonathan Jackson House Sell $1,001 - $15,000 May 27, 2026
Jonathan Jackson House Sell $1,001 - $15,000 Mar 12, 2026
Jonathan Jackson House Buy $15,001 - $50,000 Jan 8, 2026
Jonathan Jackson House Buy $1,001 - $15,000 Oct 15, 2025
Lisa McClain House Sell $1,001 - $15,000 Sep 12, 2025
Lisa McClain House Buy $1,001 - $15,000 Aug 13, 2025
John James House Sell $1,001 - $15,000 Sep 6, 2024
John James House Buy $1,001 - $15,000 Sep 2, 2024

THC FAQ

Is THC a buy?
Nama's AI scorecard currently rates Tenet Healthcare Buy (8.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is THC's P/E ratio?
Tenet Healthcare trades at a trailing price-to-earnings ratio of 12.7.
When does THC report earnings?
Tenet Healthcare's next scheduled report is on Feb 10, 2027. Analysts expect EPS of $5.41.
What is the THC price target?
The median analyst price target from 22 analysts is $303.50, with a range of $265.00 – $342.00.
Is THC Shariah compliant?
Nama's AAOIFI-style screen reads Tenet Healthcare as Not Shariah Compliant. At least one of the three ratios or the industry test failed.